Ep. 31: Advancing patient informed consent

The Latest Dose

Patients are the most important constituent in clinical development and provide the necessary information to assess the safety and efficacy of new medicines. Participation in clinical research requires informed consent. The importance of informed consent cannot be overstated – participants must completely understand all that is involved in a clinical trial prior to providing their signed consent.

In this episode, Andrea Valente, Chief Executive Officer of ClinOne, shares her thoughts on consent, informed consent, and how the principles of consent management is an important emerging approach in clinical research – a topic of particular interest as we continue to hear stories in the industry literature concerning complicated study designs, variability in literacy levels and cultural diversity in clinical research.